Bank Julius Baer & Co. Ltd Zurich Sells 8,817 Shares of Xylem Inc. $XYL

Bank Julius Baer & Co. Ltd Zurich lessened its position in shares of Xylem Inc. (NYSE:XYL) by 10.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 72,120 shares of the industrial products company’s stock after selling 8,817 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich’s holdings in Xylem were worth $9,891,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of XYL. Knuff & Co LLC bought a new stake in shares of Xylem during the 3rd quarter valued at about $27,000. Board of the Pension Protection Fund bought a new position in shares of Xylem in the 4th quarter worth approximately $27,000. Wexford Capital LP purchased a new position in shares of Xylem in the third quarter worth approximately $27,000. First Horizon Corp purchased a new position in shares of Xylem in the third quarter worth approximately $30,000. Finally, Ramirez Asset Management Inc. grew its position in Xylem by 100.0% during the third quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock valued at $30,000 after buying an additional 100 shares during the period. Institutional investors own 87.96% of the company’s stock.

Xylem Stock Up 0.3%

Shares of XYL stock opened at $109.37 on Friday. The company has a market capitalization of $26.00 billion, a price-to-earnings ratio of 27.21, a PEG ratio of 1.55 and a beta of 1.08. Xylem Inc. has a one year low of $108.96 and a one year high of $154.27. The company’s fifty day moving average price is $120.83 and its 200-day moving average price is $132.83. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The business had revenue of $2.13 billion during the quarter, compared to analyst estimates of $2.11 billion. During the same quarter in the prior year, the business posted $1.03 EPS. Xylem’s revenue for the quarter was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Sell-side analysts expect that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem declared that its board has authorized a stock buyback plan on Wednesday, February 25th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the industrial products company to purchase up to 4.8% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s board believes its stock is undervalued.

Wall Street Analyst Weigh In

Several research firms have weighed in on XYL. TD Cowen reiterated a “hold” rating on shares of Xylem in a research report on Monday, February 23rd. Mizuho set a $138.00 price objective on shares of Xylem in a research report on Wednesday, February 11th. William Blair began coverage on Xylem in a research note on Monday, January 26th. They issued an “outperform” rating for the company. Barclays lowered their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 29th. Finally, Citigroup cut their price target on Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Seven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $152.77.

Insider Activity

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jerome A. Peribere acquired 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The shares were bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the acquisition, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Company insiders own 0.32% of the company’s stock.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.